SEHK:3899
SEHK:3899Machinery

3 Asian Dividend Stocks To Watch With Up To 3.7% Yield

As the Bank of Japan raises interest rates to levels not seen in three decades and China's economic indicators reveal mixed signals, investors are closely monitoring the Asian markets for potential opportunities. In this environment, dividend stocks can offer a more stable income stream, making them an attractive option for those looking to navigate uncertain economic conditions.
SEHK:338
SEHK:338Chemicals

Asian Market Insights: SenseTime Group And 2 Other Noteworthy Penny Stocks

The Asian markets have been navigating a complex landscape, with significant developments such as the Bank of Japan raising its benchmark interest rate to the highest level in 30 years. Against this backdrop, penny stocks—though an older term—remain a relevant area for investment, particularly among smaller or newer companies that might offer unique growth opportunities. In light of current market conditions, we explore several penny stocks that exhibit financial strength and potential for...
SEHK:6618
SEHK:6618Consumer Retailing

Will JD Health’s AI-Powered Pharmacy-Plus-Online-Care Expansion Change JD Health International's (SEHK:6618) Narrative

Earlier in 2025, JD Health International expanded its “retail pharmacy + online medical service” model, reinforcing its position as China’s largest online B2C retail pharmacy while rolling out AI-powered tools such as the “Beijing Medicine Thousand Questions” medical model and intelligent assistants. By combining round-the-clock online consultations, specialized medical services, and new AI-driven products, JD Health is deepening its integrated healthcare ecosystem and broadening how users...
SEHK:1093
SEHK:1093Pharmaceuticals

CSPC Pharmaceutical Group (SEHK:1093) valuation after new CEO appointment and SYH2085 influenza trial approval

The latest move at CSPC Pharmaceutical Group (SEHK:1093) blends leadership change with pipeline progress, as the company installs a new CEO and secures trial approval for its SYH2085 influenza candidate. See our latest analysis for CSPC Pharmaceutical Group. The market seems to like this mix of fresh leadership and R&D momentum, with CSPC Pharmaceutical Group's 1 day share price return of 7.64 percent and 7 day share price return of 20.65 percent pushing the stock to HK$8.88. This backs up an...
SEHK:881
SEHK:881Specialty Retail

Zhongsheng Group Holdings (SEHK:881): Assessing Valuation After Audit Committee Leadership Transition

Zhongsheng Group Holdings (SEHK:881) just overhauled a key part of its governance, with long serving audit committee chair Ying Wei stepping down and tax specialist Bai Fengjiu taking over leadership of audit oversight. See our latest analysis for Zhongsheng Group Holdings. The governance refresh comes after a tough stretch, with a 90 day share price return of negative 19.33 percent and a three year total shareholder return of negative 67.17 percent. Investors will be watching to see if...
SEHK:2020
SEHK:2020Luxury

Assessing ANTA Sports Products (SEHK:2020) Valuation After Its Strengthened Sustainability Governance Framework Update

ANTA Sports Products (SEHK:2020) just sharpened its governance playbook by formally revising the mandate of its Sustainability Committee to tighten board oversight of ESG strategy, risk management, and disclosure across the group. See our latest analysis for ANTA Sports Products. That stronger ESG oversight comes as the share price sits at HK$82.25, with an 8.01 percent year to date share price return but a weaker 5 year total shareholder return of negative 24.19 percent. This suggests long...